• About StemCell's Contract Assay Services
  • Team
    • Jackie Damen
    • Carla Pereira
    • Katina Wong
  • History
• Services
  • Drug, Peptide and Xenobiotic Testing
  • Clinical Samples
  • Transgenic Characterization
  • Core Assay List
  • Additional Services
• Advantages of In Vitro Assays
  • Stem Cell Background
  • Why Examine Bone Marrow Toxicity?
  • Which Cells are Most Vulnerable to Toxic Insult?
• Publications And References
  • Hemotoxicity and Colony Forming Cell (CFC) Assay Publications
  • Drug Development
  • AgroChemical
  • Environmental Toxicants
  • Technical Literature
• News & Events
  • CAS Press Releases
    • Feb 20, 2008
    • Mar 14, 2007
    • Jan 7, 2007
    • Jun 26, 2006
  • Featured Content
    • Predictive Toxicology
    • Drug Screening with Primary Cells
  • Events
  • Webinars
• Home
• Site Map
• Contact Us

Team

STI Contract Assay Services’ team includes scientists with more than 30 years of experience in hematopoietic research including in vivo and in vitro assay development, toxicity study design with significant accomplishments in the field of hematopoiesis. Learn more about STI Contract Assay Services’ team by viewing our biographies.